According to a new report, published by KBV research, The Global Urology Supplements Market size is expected to reach $2.6 billion by 2030, rising at a market growth of 7.8% CAGR during the forecast period.
The Multi-ingredient segment is generating the highest revenue in the Global Urology Supplements Market by Type in 2022; thereby, achieving a market value of $1.7 billion by 2030. Multi-ingredient supplements are utilized to enhance sexual wellness and performance by addressing various factors that contribute to sexual dysfunction and libido decline. Ingredients like L-arginine, ginseng, horny goat weed (epimedium), maca root, tribulus terrestris, and zinc are commonly included in these supplements to improve blood flow, libido, testosterone levels, erectile function, and overall sexual satisfaction. The combination of multiple ingredients targets different aspects of sexual health, providing comprehensive support for individuals seeking to optimize their sexual function.
The E-commerce segment is registering a CAGR of 9.1% during (2023 - 2030). E-commerce offers unparalleled convenience and 24/7 availability, allowing consumers to shop for urology supplements at their convenience, anytime and anywhere. Online platforms enable round-the-clock access to product information, reviews, and purchasing options, eliminating the constraints of traditional retail hours and geographical limitations. Consumers can easily browse, compare, and purchase urology supplements, enhancing the overall shopping experience and satisfaction. For example, as per the International Trade Administration, global e-commerce sales for B2B businesses have gradually increased over the last decade, with the global B2B e-commerce industry expected to be worth USD$36 trillion by 2026.
The Urinary Tract infections segment is leading the Global Urology Supplements Market by Application in 2022; thereby, achieving a market value of $967.7 million by 2030. The increasing concern over antibiotic resistance and the desire to minimize antibiotic use have led many individuals to seek alternative strategies for managing UTIs. Urology supplements provide a non-pharmacological approach to UTI prevention and management, offering a valuable adjunct or alternative to antibiotic therapy. By reducing the frequency of UTIs and the need for antibiotic treatment, supplements contribute to the overall effort to combat antibiotic resistance and preserve the efficacy of antimicrobial agents.
The Softgels segment is experiencing a CAGR of 8.2% during (2023 - 2030). Softgel capsules are known for their superior bioavailability compared to other dosage forms. The lipid-based matrix of softgel capsules promotes better absorption of fat-soluble nutrients and bioactive compounds, such as vitamins, antioxidants, and herbal extracts. The encapsulation process seals the active ingredients within the softgel shell, protecting them from environmental factors, moisture, oxidation, and light that can degrade the potency and efficacy of the supplement. This extended shelf life and improved stability contribute to product quality and consumer satisfaction.
Full Report: https://www.kbvresearch.com/urology-supplements-market/
The North America region dominated the Global Urology Supplements Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $889.9 million by 2030. The Europe region is anticipating a CAGR of 7.5% during (2023 - 2030). Additionally, The Asia Pacific region would exhibit a CAGR of 8.6% during (2023 - 2030).
By Type
By Distribution Channel
By Application
By Formulation
By Geography
Unique Offerings 
